Bavarian Nordic A/S buy El_Zocko
Start price
18.04.15
/
50%
€43.30
Target price
16.06.15
€60.00
Performance (%)
-6.41%
End price
16.06.15
€40.52
Summary
This prediction ended on 16.06.15 with a price of €40.52. With a performance of -6.41%, the BUY prediction for Bavarian Nordic A/S by El_Zocko closed slightly in the red. El_Zocko has 50% into this predictionBavarian Nordic (symbol: BAVA) is a biotechnology company that specializes in developing innovative vaccines for serious diseases such as cancer and infectious diseases like Ebola and COVID-19. The company has a broad portfolio of vaccines that are under development and has collaboration agreements with various pharmaceutical companies and government agencies. Bavarian Nordic's flagship product is its cancer vaccine known as PROSTVAC, which is currently undergoing clinical trials for the treatment of prostate cancer. The company is listed on the NASDAQ Copenhagen stock exchange and has a market capitalization of approximately $925 million as of May 2021.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bavarian Nordic A/S | 1.372% | 1.372% | 25.883% | -30.280% |
| iShares Core DAX® | -5.744% | -6.037% | 9.155% | 8.257% |
| iShares Nasdaq 100 | -4.907% | -12.083% | 19.607% | 30.219% |
| iShares Nikkei 225® | -7.230% | -10.182% | 3.445% | -1.121% |
| iShares S&P 500 | -4.764% | -6.545% | 19.194% | 31.957% |
Comments by El_Zocko for this prediction
In the thread Bavarian Nordic A/S diskutieren
FC BAVARIAN NORDIC
Chance zum Einstieg nutzen!
(Vom Mitglied beendet)